A new approach to gene therapy for retinitis pigmentosa may help patients with advanced disease regain vision regardless of which genetic mutation is causing the condition. An optogenetic therapy ...

Life Biosciences is pushing cellular rejuvenation into the clinic with ER-100, an experimental gene therapy designed to restore vision by reviving damaged neurons in the eye. Rather than slowing ...

In a quiet but potentially transformative development for millions of Americans, the U.S. Food and Drug Administration (FDA) has approved a new type of daily eye drop that restores near vision without ...